Consequently, among the expressed genes of PBLs at the pre-dose time point, we identified Havcr2 as a gene that could predict complete tumor elimination by treatment with combined DSP-0509 and RT with the highest predictive performance (Supplemental Table 1). Here, HAVCR2 is linked to neoplasm.